Kazia Therapeutics Limited (KZIA)
NASDAQ·Healthcare·Biotechnology
$14.35
+4.21%
Mkt Cap $13.31M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$19.00
Range $18.00 – $20.00
Implied Upside
+32.4%
Consensus $19.00 vs current $14.35
NASDAQ·Healthcare·Biotechnology
$14.35
+4.21%
Mkt Cap $13.31M
No recent rating data.
Price Target (2 analysts)
$19.00
Range $18.00 – $20.00
+32.4%
Consensus $19.00 vs current $14.35